Marc Turner

Additional publications:

Ivanovs A, Rybtsov S, Welch L, Anderson RA, Turner ML, Medvinsky A. Highly potent human hematopoietic stem cells first emerge in the intra-embryonic aorta-gonad-mesonephros region. The Journal of Experimental Medicine 2011; 208: 2417-27.
Padfield GJ, Tura-Ceide O, Freyer E, Barclay GR, Turner M, Newby DE, Mills NL. Endothelial cells, atheroma burden and clinical outcome in patients with coronary artery disease. Heart 2013; 99: 791-798.
Barr LC, Brittan M, Morris AC, McAuley DF, McCormack C, Fletcher AM, Richardson H, Connell M, Patel D, Wallace WAH, Rossi AG, Davidson DJ, Manson L, Turner ML, Hirani N, Walsh TS, Anderson N, Dhaliwal K, Simpson AJ. A randomised controlled trial of peripheral blood mononuclear cell depletion for experimental human acute lung inflammation. American Journal of Respiratory and Critical Care Medicine 2013; 188:449-455.
Turner M, Leslie S, Martin N, Peschanski M, Rao M, Taylor CJ, Trounson A, Turner D, Yamanaka S, Wilmut I. Towards the development of a global induced pluripotent stem cell library. Cell Stem Cell 2013; 13: 382-384.
Ivanovs A, Rybtsov S, Anderson RA, Turner ML, Medvinsky A. Identification of the niche and phenotype of the first human hematopoietic stem cells. Stem Cell Reports 27 March 2014; 10.1016/j.stemcr.2014.02.004

Publications

2013

Toward the development of a global induced pluripotent stem cell library. Turner, Marc L., Leslie Stephen, Martin Nicholas G., Peschanski Marc, Rao Mahendra, Taylor Craig J., Trounson Alan, Turner David, Yamanaka Shinya, and Wilmut Ian , Cell Stem Cell, 2013 Oct 3, Volume 13, Issue 4, p.382-4, (2013)

Postmenstrual gestational age should be used with care in studies of early human hematopoietic development. Ivanovs, Andrejs, Rybtsov Stanislav, Anderson Richard A., Turner Marc L., and Medvinsky A L. , Blood, 2013 Apr 11, Volume 121, Issue 15, p.3051-2, (2013)

Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow. Tura, Olga, Skinner Elizabeth M., Barclay G R., Samuel Kay, Gallagher Ronald C. J., Brittan Mairi, Hadoke Patrick W. F., Newby D E., Turner Marc L., and Mills N L. , Stem Cells, 2013 Feb, Volume 31, Issue 2, p.338-48, (2013)

2012

Novel biopolymers to enhance endothelialisation of intra-vascular devices. Pernagallo, Salvatore, Tura Olga, Wu Mei, Samuel Kay, Diaz-Mochon Juan Jose, Hansen Anna, Zhang Rong, Jackson Melany, Padfield G J., Hadoke Patrick W. F., et al. , Adv Healthc Mater, 2012 Sep, Volume 1, Issue 5, p.646-56, (2012)

2011

Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. Ivanovs, Andrejs, Rybtsov Stanislav, Welch Lindsey, Anderson Richard A., Turner Marc L., and Medvinsky A L. , J Exp Med, 2011 Nov 21, Volume 208, Issue 12, p.2417-27, (2011)

Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitro. Krejciova, Zuzana, Pells Steve, Cancellotti Enrico, Freile Paz, Bishop Matthew, Samuel Kay, Barclay G R., Ironside James W., Manson Jean C., Turner Marc L., et al. , J Pathol, 2011 Apr, Volume 223, Issue 5, p.635-45, (2011)

2010

Red blood cells from pluripotent stem cells for use in transfusion. Mountford, Joanne C., Olivier Emmanuel, Jordanides Niove E., de Sousa Paul, and Turner Marc L. , Regen Med, 2010 May, Volume 5, Issue 3, p.411-23, (2010)

Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy. Tura, O, Crawford J, Barclay G R., Samuel Kay, Hadoke Patrick W. F., Roddie H, Davies J, and Turner Marc L. , J Thromb Haemost, 2010 Jul, Volume 8, Issue 7, p.1614-23, (2010)

2009

Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention. Mills, N L., Tura O, Padfield G J., Millar C, Lang N N., Stirling D, Ludlam C, Turner Marc L., Barclay G R., and Newby D E. , Heart, 2009 Dec, Volume 95, Issue 24, p.2003-8, (2009)

Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Jones, Michael, Peden Alexander H., Yull Helen, Wight Darren, Bishop Matthew T., Prowse Chris V., Turner Marc L., Ironside James W., MacGregor Ian R., and Head Mark W. , Transfusion, 2009 Feb, Volume 49, Issue 2, p.376-84, (2009)

Search form